PharmaShots

JUNE 9, 2023

Quell Therapeutics Signed an Exclusive Option and License Agreement with AstraZeneca to Develop, Manufacture and Commercialize Engineered Treg Cell Therapies Date: June 09, 2023 | Tags: Quell Therapeutics, AstraZeneca, Engineered Treg Cell Therapies, Type 1 Diabetes, Inflammatory Bowel Disease, Biotech, Treg cell engineering modules Astellas and the (..)

FDA 40

FDA 40

pharmaphorum

NOVEMBER 24, 2022

Johnson & Johnson’s Spravato therapy for treatment-resistant depression (TRD) hasn’t made the impact the company hoped for in the market, and it is looking to new clinical results to accelerate its take-up. and 17.6%, respectively, according to J&J’s pharma unit Janssen. and 14.1%, respectively.

Labelling 52

Labelling Hospitals 52

The Checkup by Singlecare

JANUARY 19, 2023

Although you can test your blood sugar at home, it is best to see a healthcare professional for a medical diagnosis—and treatment if required. Symptoms of high blood sugar generally require treatment. Read more about high blood sugar treatments here. DKA is a medical emergency and requires treatment in the hospital.

Immunization 105

Immunization Hospitals Communication 105